Isolation and characterization of N‐(2‐Hydroxyethyl)hexadecanamide from Colletotrichum gloeosporioides with apoptosis‐inducing potential in breast cancer cells

Abstract

AbstractEndophytic fungi are a well‐established reservoir of bioactive compounds that are pharmaceutically valuable and therefore, contribute significantly to the biomedical field. The present study aims to identify the bioactive anticancer compound from ethyl acetate extract of fungal endophyte, Colletotrichum gloeosporioides associated with the leaf of the medicinal plant Oroxylum indicum. The fatty acid amide compound N‐(2‐Hydroxyethyl)hexadecanamide (Palmitoylethanolamide; PEA) was identified using antioxidant activity‐guided fractionation assisted with tandem liquid chromatography coupled with quadrupole time of flight mass spectrometry, Fourier transform‐infrared spectroscopy, time‐of‐flight mass spectrometry, and nuclear magnetic resonance. In‐Silico molecular docking analysis showed that PEA potentially docked to the active sites of apoptosis‐inducing proteins including BAX, BCL‐2, P21, and P53. Further validation was done using in vitro study that showed PEA inhibitsthe proliferation, alters nuclear morphology and attenuates the wound closure ability of MDA‐MB‐231 and MCF‐7 cells. PEA induces apoptosis via upregulating cell‐cycle arrest (P21), tumor suppression (P53), pro‐apoptotic (BAX, CASPASE‐8, and FADD) genes, and downregulating anti‐apoptotic gene BCL‐2. The upregulation of the active form of Caspase‐3 was also reported. This is the first‐ever report for the isolation of PEA from C. gloeosporioides with anticancer activity against human breast cancer cells and therefore holds great potential for future therapeutics.